For instance, in cardiovascular diseases-related studies, elevated plasma IPA levels have been shown to activate PXR in platelets, subsequently inhibiting downstream signaling pathways and suppressing platelet activation, thereby effectively preventing thrombosis [66]. Here, NR1I2 is linked to cardiovascular disorder.